http://articles.mercola.com/sites/articles/archive/2005/12/27/is-a-mistrial-good-news-for-merck.aspxThe first federal trial against pharmaceutical giant Merck over the health risks of Vioxx, the controversial painkiller, ended in a mistrial Monday. A sole juror voting in favor of the plaintiff deadlocked the Houston jury, meaning that the question ofenCommunityServer 2008.5 SP1 (Build: 31106.3070)